Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nyxoah Ord Shs NYXH

Healthcare Medical Devices
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every... see more

Recent & Breaking News (NDAQ:NYXH)

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer

GlobeNewswire 12 days ago

Information on the total number of voting rights and shares

GlobeNewswire March 29, 2024

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology - Head & Neck Surgery Foundation

GlobeNewswire March 25, 2024

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints

GlobeNewswire March 19, 2024

Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results

GlobeNewswire March 5, 2024

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

GlobeNewswire February 29, 2024

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024

GlobeNewswire February 15, 2024

Nyxoah Announces 2024 Strategic Priorities

GlobeNewswire January 17, 2024

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023

GlobeNewswire January 9, 2024

Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®

GlobeNewswire December 11, 2023

Publication Relating to a Transparency Notification

GlobeNewswire December 8, 2023

Nyxoah Strengthens its Executive Leadership Team

GlobeNewswire November 28, 2023

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire November 21, 2023

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

GlobeNewswire November 8, 2023

Nyxoah to Participate in the Jefferies London Healthcare Conference

GlobeNewswire November 7, 2023

Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023

GlobeNewswire October 26, 2023

Nyxoah Announces Partnership with ResMed in Germany

GlobeNewswire September 28, 2023

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 12, 2023

Nyxoah to Participate in Upcoming Investor Conferences

GlobeNewswire September 5, 2023

Information on the Total Number of Voting Rights and Shares

GlobeNewswire August 30, 2023